TruSight Oncology 500

Assay targeting multiple variant types, including microsatellite instability (MSI) and tumor mutational burden (TMB). Read More...
Select Product(s)
Manual Prep

TruSight Oncology 500 DNA Kit (48 samples)

20028213

Price
 
 

TruSight Oncology 500 DNA Kit, For Use with NextSeq (48 samples)

20028214

Price
 
 

TruSight Oncology 500 DNA/RNA Bundle, (16 indexes, 24 samples)

20028215

Price
 
 

TruSight Oncology 500 DNA/RNA Bundle, for use with NextSeq (16 indexes, 24 samples)

20028216

Price
 
 

TruSight Oncology 500 DNA Kit plus PierianDx interpretation report (16 indexes, 48 Samples)

20032624

Price
 
 

TruSight Oncology 500 DNA Kit for Use with NextSeq plus PierianDx interpretation report (16 indexes, 48 Samples)

20032625

Price
 
 

TruSight Oncology 500 DNA/RNA Bundle plus PierianDx interpretation report (16 indexes, 24 Samples)

20032626

Price
 
 

TruSight Oncology 500 DNA/RNA Kit for Use with NextSeq plus PierianDx interpretation report (16 indexes, 24 Samples)

20032627

Price
 
 

Automation

TruSight Oncology 500 DNA Automation Kit (16 indexes, 64 Samples)

20045504

Price
 
 

TruSight Oncology 500 DNA Automation Kit, For Use with NextSeq (16 indexes, 64 Samples)

20045505

Price
 
 

TruSight Oncology 500 DNA Automation Kit + PierianDx plus PierianDx interpretation report (16 indexes, 64 samples)

20045506

Price
 
 

TruSight Oncology 500 DNA Automation Kit plus PierianDx interpretation report, for Use with NextSeq + PierianDx (16 indexes, 64 samples)

20045507

Price
 
 

TruSight Oncology 500 DNA/RNA Automation Kit (16 indexes, 32 Samples)

20045508

Price
 
 

TruSight Oncology 500 DNA/RNA Automation Kit plus PierianDx interpretation report (16 indexes, 32 Samples)

20045509

Price
 
 

TruSight Oncology 500 DNA/RNA Automation Kit, For Use with NextSeq (16 indexes, 32 Samples)

20045990

Price
 
 

TruSight Oncology 500 DNA/RNA Automation Kit plus PierianDx interpretation report, For Use with NextSeq (16 indexes, 32 Samples)

20045991

Price
 
 

Services

Trusight Oncology 500 Training (DNA) - Customer Site

20031667

Price
 
 

Trusight Oncology 500 Training (DNA and RNA) - Customer Site

20031668

Price
 
 

Product Highlights

TruSight Oncology 500 is a next-generation sequencing (NGS) assay that enables in-house comprehensive genomic profiling of tumor samples. It supports identification of all relevant DNA and RNA variants implicated in various solid tumor types.

In addition, it accurately measures key current immuno-oncology biomarkers: microsatellite instability (MSI) and tumor mutational burden (TMB).

Consolidate Multiple Biomarker Assays into One

  • Pan-cancer biomarker content aligned with key guidelines and clinical trials
  • DNA + RNA assay targeting 523 genes for assessment of all DNA and RNA variant types, plus MSI and TMB
  • Increase chances of finding a positive biomarker by moving from individual biomarker assays to a single comprehensive NGS assay

Streamlined Sample-to-Results Workflow

  • Go from initial sample to results in 4-5 days
  • Automation kits and methods available for reduced hands-on time and scalability
  • Easily translate raw data into a final interpretation report, powered by PierianDx Clinical Genomics Workspace (CGW) software.

Achieve Highly Confident Results

  • Hybrid-capture chemistry combined with sophisticated bioinformatics, leading to high analytical specificity and sensitivity
  • Inclusive of unique molecular indexes (UMIs) for high sensitivity in variant detection
  • Based on proven Illumina SBS sequencing technology

Enable In-House Comprehensive Genomic Profiling

  • Keep samples and data in house, for more control and ability to build a database
  • A future-proof assay with emerging biomarkers already included
Learn more about TruSight Oncology 500 Family

TruSight Oncology 500 Product Family

All three assays in the family are designed to identify key biomarkers in guidelines and clinical trials.

TruSight Oncology 500 Assay

Assess relevant biomarkers from FFPE tumor tissue with the TruSight Oncology 500 Assay.

TruSight Oncology 500 High-Throughput Assay

Batch up to 192 samples at a time while using the same biomarkers and tissue type as the TruSight Oncology 500 assay.

TruSight Oncology 500 ctDNA Assay

Analyze circulating tumor DNA from plasma with the TruSight Oncology 500 ctDNA assay.

Purchasing the TruSight Oncology 500 assay for the first time?

Complete the form to receive information about the first-time TruSight Oncology 500 purchase program.

Frequently Purchased Together

Specifications

Product Comparison

TruSight Oncology 500 TruSight Oncology 500 High-Throughput TruSight Oncology 500 ctDNA
Cancer Type Pan-Cancer Pan-Cancer Pan-Cancer
Content Specifications Targeted selection of DNA from 523 genes of interest, and RNA from 55 genes, for a total of 1.94Mb panel size.
• Guideline Coverage: Broad coverage of key guidelines for multiple solid tumor types
• Clinical Trials Coverage: Over 1,000 clinical trials
• Immuno-oncology Biomarker Coverage: Biomarkers TMB and MSI included; also inclusive of HLA regions, POLE1 and POLD1*.
Targeted selection of DNA from 523 genes of interest, and RNA from 55 genes, for a total of 1.94Mb panel size.
• Guideline Coverage: Broad coverage of key guidelines for multiple solid tumor types
• Clinical Trials Coverage: Over 1,000 clinical trials
• Immuno-oncology Biomarker Coverage: Biomarkers TMB and MSI included; also inclusive of HLA regions, POLE1 and POLD1*.
Targeted selection of 523 genes (full coding sequence) for a total of 1.94Mb panel size.
• Guideline Coverage: Broad coverage of key guidelines for multiple solid tumor types
• Immuno-oncology Biomarker Coverage: TMB and MSI*
Hands-On Time ~10.5 hours ~10.5 hours ~10.5 hours
Input Quantity 40 ng DNA, 40 ng RNA 40 ng DNA, 40-80 ng RNA (need at least 2 mm3 FFPE tissue) 30 ng cfDNA (8-10 ml of plasma)
Method Target Enrichment , Targeted DNA Sequencing , Targeted RNA Sequencing Target Enrichment , Targeted DNA Sequencing , Targeted RNA Sequencing Target Enrichment , Targeted DNA Sequencing
Nucleic Acid Type DNA, RNA DNA, RNA DNA
Specialized Sample Types FFPE Tissue FFPE Tissue Blood, Cell-Free DNA
Species Category Human Human Human
System Compatibility NextSeq 500 , NextSeq 550 , NextSeq 550Dx in Research Mode NovaSeq 6000 NovaSeq 6000
Technology Sequencing Sequencing Sequencing
Variant Class Copy Number Variants (CNVs), Gene Fusions, Insertions-Deletions (indels), Single Nucleotide Variants (SNVs), Transcript Variants Copy Number Variants (CNVs), Gene Fusions, Insertions-Deletions (indels), Single Nucleotide Variants (SNVs), Transcript Variants Copy Number Variants (CNVs), Gene Fusions, Insertions-Deletions (indels), Single Nucleotide Variants (SNVs), Somatic Variants

Based on PierianDx Clinical knowledgebase, as of March 2020

Analytical Evaluation & Verification Service

The TruSight Oncology 500 Analytical Evaluation Service* is a set of tools intended to guide you in aligning with the latest CAP, AMP, and European standards. We provide recommendations to help you evaluate analytical performance characteristics and integrate products into your workflows.

Learn More
Analytical Evaluation & Verification Service

* This service is available in select countries and regions.

Method-Specific Workflow Example

 

Supporting Data and Figures

 
Detection of currently relevant DNA & RNA variants for multiple types of cancer. Some key biomarkers include:
Pan-Cancer Biomarkers
NTRK1        NTRK2        NTRK3        MSI
Lung Melanoma Colon Ovarian Breast Gastric Bladder Sarcoma
AKT1 BRAF AKT1 BRAF AKT1 BRAF MSH5 ALK
ALK CTNNB1 BRAF BRCA1 AR KIT PMS2 APC
BRAF GNA11 HRAS BRCA2 BRCA1 KRAS TSC1 BRAF
DDR2 GNAQ KRAS KRAS BRCA2 MET   CDK4
EGFR KIT MET PDGFRA ERBB2 MLH1   CTNNB1
ERBB2 MAP2K1 MLH1 FOXL2 FGFR1 PDGFRA   ETV6
FGFR1 NF1 MSH2 TP53 FGFR2 TP53   EWSR1
FGFR3 NRAS MSH6   PIK3CA     FOXO1
KRAS PDGFRA NRAS   PTEN     GLI1
MAP2K1 PIK3CA PIK3CA         KJT
MET PTEN PMS2         MDM2
NRAS TP53 PTEN         MYOD1
PIK3CA   SMAD4         NAB2
PTEN   TP53         NF1
RET             PAX3
TP53             PAX7
TMB             PDGFRA
              PDGFRB
              SDHB
              SDHC
              SMARCB1
              TFE3
              WT1

The genes and biomarkers listed in this table are a subset of all genes included in the panel. To see the full gene list, view the product datasheet, available under Product Literature on this page.

* The product to evaluate DNA & RNA variants is the TruSight Oncology 500 DNA/RNA Bundle.

Related Products